DE69322896D1 - Verwendung von Proteinen der Transferrin/Lactoferrin-Familie zur Stimulation des Immunsystems - Google Patents

Verwendung von Proteinen der Transferrin/Lactoferrin-Familie zur Stimulation des Immunsystems

Info

Publication number
DE69322896D1
DE69322896D1 DE69322896T DE69322896T DE69322896D1 DE 69322896 D1 DE69322896 D1 DE 69322896D1 DE 69322896 T DE69322896 T DE 69322896T DE 69322896 T DE69322896 T DE 69322896T DE 69322896 D1 DE69322896 D1 DE 69322896D1
Authority
DE
Germany
Prior art keywords
transferrin
stimulate
proteins
immune system
lactoferrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69322896T
Other languages
English (en)
Other versions
DE69322896T2 (de
Inventor
Kunio Ando
Junichi Kishimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JAPAN IMMUNO Inc
Original Assignee
JAPAN IMMUNO Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=14096242&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69322896(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP4093933A external-priority patent/JPH06316529A/ja
Application filed by JAPAN IMMUNO Inc filed Critical JAPAN IMMUNO Inc
Application granted granted Critical
Publication of DE69322896D1 publication Critical patent/DE69322896D1/de
Publication of DE69322896T2 publication Critical patent/DE69322896T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69322896T 1992-03-02 1993-03-01 Verwendung von Proteinen der Transferrin/Lactoferrin-Familie zur Stimulation des Immunsystems Expired - Fee Related DE69322896T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4093933A JPH06316529A (ja) 1991-12-03 1992-03-02 レンチウイルス感染に随伴する日和見感染症の治療予 防用医薬組成物

Publications (2)

Publication Number Publication Date
DE69322896D1 true DE69322896D1 (de) 1999-02-18
DE69322896T2 DE69322896T2 (de) 1999-05-27

Family

ID=14096242

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69322896T Expired - Fee Related DE69322896T2 (de) 1992-03-02 1993-03-01 Verwendung von Proteinen der Transferrin/Lactoferrin-Familie zur Stimulation des Immunsystems

Country Status (5)

Country Link
US (1) US5576299A (de)
EP (1) EP0559425B1 (de)
CA (1) CA2090658A1 (de)
DE (1) DE69322896T2 (de)
DK (1) DK0559425T3 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3100005B2 (ja) * 1992-07-28 2000-10-16 雪印乳業株式会社 ヒト免疫不全ウィルス感染・増殖抑制剤
JP3312946B2 (ja) * 1993-03-04 2002-08-12 雪印乳業株式会社 ウイルス感染・増殖抑制剤
JPH08217693A (ja) * 1995-02-17 1996-08-27 Yoshihisa Naito 新規医薬組成物
US5869446A (en) * 1996-07-09 1999-02-09 Gambit International Limited Preparation of lactoferrin (or serotransferrin or ovotransferrin) and desferrioxamine methanesulfonate (or other low molecular weight metal ion chelators) for the therapy of viral infections
WO1998050076A1 (en) * 1997-05-03 1998-11-12 Board Of Regents, The University Of Texas System Methods for preventing and treating the insult-induced metabolic imbalance in humans and other animals
US6333047B1 (en) 1997-05-09 2001-12-25 Daiichi Kasei Co., Ltd. Molded capsule superior in strength and stability and method for preparing same
JP3188649B2 (ja) * 1997-05-09 2001-07-16 株式会社第一化成 カプセル
DE19844022C1 (de) * 1998-09-25 2000-05-25 Sherif Sabry Ragab Mekkawi Verwendung von eisenbindenden Glycoproteinen und/oder 10-Hydroxy-2-decensäure in Verbindung mit Thymochinon zur Behandlung von AIDS
US6399570B1 (en) * 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
IT1317937B1 (it) * 2000-11-17 2003-07-15 Sigma Tau Healthscience Spa Composizione per stimolare le difese immunitarie ed il metabolismo delferro comprendente una alcanoil l-carnitina e lattoferrina.
US6482396B1 (en) * 2001-05-15 2002-11-19 Campina Melkunie B.V. Methods for treating or preventing diseases of the oral cavity
WO2003047363A1 (en) * 2001-12-05 2003-06-12 Dsm Ip Assets B.V. Methods and compositions for use in pet breeding
EP2386311A1 (de) * 2001-12-28 2011-11-16 NRL Pharma, Inc. Zusammensetzungen zur Verbesserung des Fettstoffwechsels
WO2003061688A1 (fr) * 2002-01-21 2003-07-31 Nrl Pharma, Inc. Nouveaux analgesiques
DK1545587T3 (da) * 2002-09-16 2011-05-09 Agennix Inc Lactoferrinsammensætninger og fremgangsmåder til behandling af diabetiske sår
CA2485957A1 (en) * 2002-11-29 2004-06-17 Nobuhiko Katunuma Protease inhibitor
CA2508912A1 (en) * 2002-12-06 2004-06-24 Agennix Incorporated Oral lactoferrin in the treatment of sepsis
AU2003293500A1 (en) * 2002-12-12 2004-07-09 Agennix Incorporated Lactoferrin in the reduction of pain
GB0229658D0 (en) * 2002-12-20 2003-01-22 Cleeve Richard J Bird feed
WO2004103285A2 (en) * 2003-05-14 2004-12-02 Agennix Incorporated Lactoferrin in the treatment of diabetes mellitus
CA2532831A1 (en) * 2003-07-16 2005-03-31 The Research Foundation Of State University Of New York Host defense factor x (hdfx)
US7183381B2 (en) 2004-10-26 2007-02-27 Agennix, Inc. Composition of lactoferrin related peptides and uses thereof
US8685478B2 (en) 2005-11-21 2014-04-01 Philip Morris Usa Inc. Flavor pouch
ITMI20052351A1 (it) * 2005-12-09 2007-06-10 Microbo Srl Nuovo uso farmaceutico delle transferrine e composizioni farmaceutiche derivate
US7921231B2 (en) * 2008-01-04 2011-04-05 Silicon Image, Inc. Discovery of electronic devices utilizing a control bus
WO2009102677A1 (en) * 2008-02-11 2009-08-20 Tabatchnick Fine Foods, Inc. A nutritionally enhanced therapeutic preventative food supplement and method of making same
US7953829B2 (en) * 2009-02-05 2011-05-31 At&T Mobility Ii Llc System and method for quality of service (QoS) parameter change
ES2642324T3 (es) 2010-08-07 2017-11-16 The Research Foundation For The State University Of New York Composiciones orales que comprenden un compuesto de zinc y un agente antimicrobiano
JPWO2016056665A1 (ja) * 2014-10-08 2017-08-10 学校法人慶應義塾 白血球の細胞外トラップ形成の阻害剤
CA3103914A1 (en) 2018-06-25 2020-01-02 Triumph Pharmaceuticals Inc. Methods of inhibiting microbial infections using zinc-containing compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5093115A (en) * 1985-06-11 1992-03-03 The United States Of America As Represented By The Department Of Health And Human Services Method of preparing activated killer monocytes for treating colorectal cancer
DE3683956D1 (de) * 1985-06-11 1992-04-02 Us Commerce In einem serumfreien medium in suspension kultivierte humane monozyten.
US4977137B1 (en) * 1987-06-03 1994-06-28 Baylor College Medicine Lactoferrin as a dietary ingredient promoting the growth of the gastrointestinal tract
JP2787220B2 (ja) * 1989-03-08 1998-08-13 雪印乳業株式会社 ウィルス感染防御剤
US5158979A (en) * 1989-04-19 1992-10-27 New York University Method and compositions for treating pneumocystic carini infections
JPH03181421A (ja) * 1989-12-08 1991-08-07 Chugai Pharmaceut Co Ltd ベータラクタム系抗生物質の作用増強剤並びに感染症予防及び治療用の医薬組成物
US5198419A (en) * 1989-12-08 1993-03-30 Immuno Japan Inc. Formulated medicines for enhancing the efficacy of beta-lactam antibiotics in prophylaxis and treatment against infectious disease due to pathogenic bacteria

Also Published As

Publication number Publication date
CA2090658A1 (en) 1993-09-03
DK0559425T3 (da) 1999-08-30
US5576299A (en) 1996-11-19
DE69322896T2 (de) 1999-05-27
EP0559425A1 (de) 1993-09-08
EP0559425B1 (de) 1999-01-07

Similar Documents

Publication Publication Date Title
DE69322896D1 (de) Verwendung von Proteinen der Transferrin/Lactoferrin-Familie zur Stimulation des Immunsystems
DE69034135D1 (de) DNS-Konstrukten zur Aktivierung und Veränderung der Expression von endogenen Genen
DK448286A (da) Methionin-aminopeptidase og fremgangsmaade til fremstilling af sammefra bakterier samt fremgangsmaade til fremstilling af rekombinant protein uden n-terminal methionin
DE59310137D1 (de) Verwendung von substituierten Benzimidazolen zur Bekämpfung parasitärer Protozoen
DE69310560D1 (de) Massnahmen zur Verbesserung von digitalen Filtern
ATA53492A (de) Verwendung von ciclosporin zur pulmonalen verabreichung
ATE327331T1 (de) Rekombinante antikörper zur humanen therapie
DE69331507D1 (de) Verfahren zur Reinigung von menschlichem, rekombinantem Serumalbumin
DE3667378D1 (de) Verwendung von n-(4-phenoxy-2,6-diisopropylphenyl)-n'-tert.butylthioharnstoff zur bekaempfung von weissen fliegen.
ATE219928T1 (de) Verwendung von angiogenese-suppressoren zur hemmung des haarwuchses
NZ193487A (en) Purification of human le form interferon proteins and antibodies thereto
DE69133593D1 (de) Menschliches CNP-Gen und Vorläuferprotein
MX7531E (es) Proceso biotecnologico para alterar la proliferacion y/o el desarrollo de cultivos tisulares
DE69218734D1 (de) Verfahren zur Geschlechtsbestimmung von Rinderembryos
ATE286510T1 (de) In der behandlung von il4 auslösenden krankheiten nützliche rekombinante il4 antikörper
DE3686130D1 (de) Geschmackskontrolle von proteinhydrolysaten.
DE19681439T1 (de) Modifizierung von Polypeptidarzneimitteln zur Erhöhung des Elektrotransportflusses
DE3885913D1 (de) Aufbereitung von Alkoxysilanen.
FI941749A (fi) Rekombinantti-Borrelia -proteiinien valmistus
ATE270102T1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
DE3852625D1 (de) Vektoren und Verbindungen zur Expression von Zymogen-Formen von menschlichem Protein C.
PT86581A (de) Verwendung von bakterienlysierendem enzymprodukt aus streptomyceten zur haltbarmachung von frischfleisch
DE69017825D1 (de) Heilverfahren von Lebererkrankungen mit Verwendung von Pyrrol-Chinolin-Chinone-Triester und neue Pyrrol-Chinolin-Chinone-Triester.
DE3584719D1 (de) Verwendung von nisin zur verhinderung des verderbens alkoholischer getraenke.
FI944997A0 (fi) Parannettu rekombinantti-proteiinien tuotanto

Legal Events

Date Code Title Description
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee